These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35058917)

  • 1. New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection.
    Espinar-Buitrago M; Muñoz-Fernández MA
    Front Immunol; 2021; 12():719664. PubMed ID: 35058917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.
    Walsh SR; Bhardwaj N; Gandhil RT
    Curr HIV Res; 2003 Apr; 1(2):205-16. PubMed ID: 15043203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.
    de Jong W; Aerts J; Allard S; Brander C; Buyze J; Florence E; van Gorp E; Vanham G; Leal L; Mothe B; Thielemans K; Plana M; Garcia F; Gruters R;
    Trials; 2019 Jun; 20(1):361. PubMed ID: 31208472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
    Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
    PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook.
    Mohamed H; Miller V; Jennings SR; Wigdahl B; Krebs FC
    J Immunol Res; 2020; 2020():9470102. PubMed ID: 32537473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell based vaccines for HIV infection: the way ahead.
    García F; Plana M; Climent N; León A; Gatell JM; Gallart T
    Hum Vaccin Immunother; 2013 Nov; 9(11):2445-52. PubMed ID: 23912672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic Cells, the Double Agent in the War Against HIV-1.
    Martín-Moreno A; Muñoz-Fernández MA
    Front Immunol; 2019; 10():2485. PubMed ID: 31708924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.
    Vacas-Córdoba E; Climent N; De La Mata FJ; Plana M; Gómez R; Pion M; García F; Muñoz-Fernández MÁ
    Nanomedicine (Lond); 2014 Dec; 9(17):2683-702. PubMed ID: 25529571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanochemistry-based immunotherapy for HIV-1.
    Lori F; Calarota SA; Lisziewicz J
    Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes.
    Niu L; Termini JM; Kanagavelu SK; Gupta S; Rolland MM; Kulkarni V; Pavlakis GN; Felber BK; Mullins JI; Fischl MA; Stone GW
    Vaccine; 2011 Mar; 29(11):2110-9. PubMed ID: 21241732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates.
    Hadi A; Rastgoo A; Eskandarian M; Haghighipour N; Bolhassani A
    J Immunol Res; 2021; 2021():5538348. PubMed ID: 33997055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.
    Engelmayer J; Larsson M; Lee A; Lee M; Cox WI; Steinman RM; Bhardwaj N
    J Virol; 2001 Mar; 75(5):2142-53. PubMed ID: 11160718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.
    García F; Climent N; Guardo AC; Gil C; León A; Autran B; Lifson JD; Martínez-Picado J; Dalmau J; Clotet B; Gatell JM; Plana M; Gallart T;
    Sci Transl Med; 2013 Jan; 5(166):166ra2. PubMed ID: 23283367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dendritic cells in the pathogenesis of HIV-1 infection.
    Lore K; Larsson M
    APMIS; 2003; 111(7-8):776-88. PubMed ID: 12974779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1.
    García F; Routy JP
    Vaccine; 2011 Sep; 29(38):6454-63. PubMed ID: 21791232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.